How do you pay?

How to pay the least

Ask for the cash price

Zarxio

Zarxio is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Zarxio’s cash price, and one or two other pharmacies too.
  2. Zarxio’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Sandoz Patient Assistance (SPA). Have an adjusted annual household income of ≤300% of the federal poverty level (FPL) Or call 1-833-472-6369.

See if you qualify 

Compare every option

Question
Brand nameZarxio
Authorized genericfilgrastim-sndz
Regular genericfilgrastim-sndz
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Zarxio?
The original
–
–

Brand nameThe maker’s card

ZARXIO Co-Pay Program (Sandoz One Source)

Savings card from Sandoz

No insuranceNeeds insuranceNo cash price listed.
Insurance $0 a fill

Sign up on zarxio.com 

From the maker’s offer on zarxio.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Zarxio itself, from the same company, sold without the brand name, and usually for less. For now Zarxio is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Zarxio is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ZARXIO is a leukocyte growth factor indicated to

  • Decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti‑cancer drugs associated with a significant incidence of severe neutropenia with fever
  • Reduce the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia (AML)
  • Reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BMT)
  • Mobilize autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis
  • Reduce the incidence and duration of sequelae of severe neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia
  • Increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome)

Source: the FDA label for Zarxio (Sandoz Inc.), August 29, 2025. Full label on DailyMed 

Good to know